EDGAR Filing Documents for 0001683168-22-008095

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001683168-22-008095

Filing Date

2022-11-30

Accepted

2022-11-30 10:40:22

Documents

Period of Report

2022-08-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	cnbx_i10k-083122.htm iXBRL	10-K	948502
2	CERTIFICATION	cnbx_ex3101.htm	EX-31.1	11224
3	CERTIFICATION	cnbx_ex3102.htm	EX-31.2	11348
4	CERTIFICATION	cnbx_ex3201.htm	EX-32.1	4275
5	CERTIFICATION	cnbx_ex3202.htm	EX-32.2	4484
6	FORM OF AUDIT COMMITTEE CHARTER	cnbx_ex9901.htm	EX-99.1	45470
7	FORM OF COMPENSATION COMMITTEE CHARTER	cnbx_ex9902.htm	EX-99.2	34779
8	GRAPHIC	image_001.jpg	GRAPHIC	15711
9	GRAPHIC	image_002.jpg	GRAPHIC	19093
10	GRAPHIC	image_003.jpg	GRAPHIC	14721
11	GRAPHIC	image_004.jpg	GRAPHIC	8422
12	GRAPHIC	image_005.jpg	GRAPHIC	37166
13	GRAPHIC	image_006.jpg	GRAPHIC	22797
14	GRAPHIC	image_007.jpg	GRAPHIC	24922
15	GRAPHIC	image_008.jpg	GRAPHIC	31797
16	GRAPHIC	image_009.jpg	GRAPHIC	3761
17	GRAPHIC	image_010.jpg	GRAPHIC	30860
18	GRAPHIC	image_011.jpg	GRAPHIC	6253
19	GRAPHIC	image_012.jpg	GRAPHIC	1699
20	GRAPHIC	image_013.jpg	GRAPHIC	19098
21	GRAPHIC	image_015.jpg	GRAPHIC	2931
	Complete submission text file	0001683168-22-008095.txt		4298214

Data Files

Seq	Description	Document	Type	Size
22	XBRL SCHEMA FILE	cnbx-20220831.xsd	EX-101.SCH	24841
23	XBRL CALCULATION FILE	cnbx-20220831_cal.xml	EX-101.CAL	35582
24	XBRL DEFINITION FILE	cnbx-20220831_def.xml	EX-101.DEF	91630
25	XBRL LABEL FILE	cnbx-20220831_lab.xml	EX-101.LAB	214543
26	XBRL PRESENTATION FILE	cnbx-20220831_pre.xml	EX-101.PRE	176733
65	EXTRACTED XBRL INSTANCE DOCUMENT	cnbx_i10k-083122_htm.xml	XML	368461

Mailing Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814

Business Address #3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 877-424-2429

CNBX Pharmaceuticals Inc. (Filer) CIK: 0001343009 (see all company filings)